Article
Genetic Evaluation in a Cohort of 126 Dutch Pulmonary Arterial Hypertension Patients.
Genes - 13 Oct 2020
van den Heuvel Lieke M, Jansen Samara M A, Alsters Suzanne I M, Post Marco C, van der Smagt Jasper J, Handoko-De Man Frances S, van Tintelen J Peter, Gille Hans, Christiaans Imke, Vonk Noordegraaf Anton, Bogaard HarmJan, Houweling Arjan C
Abstract excerpt
Pulmonary arterial hypertension (PAH) is a severe, life-threatening disease, and in some cases is caused by genetic defects. This study sought to assess the diagnostic yield of genetic testing in a Dutch cohort of 126 PAH patients. Historically, genetic testing in the Netherlands consisted of the analysis of BMPR2 and SMAD9. These genes were analyzed in 70 of the 126 patients. A (likely) pathogenic (LP/P) variant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
